RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect
Retinoid X receptor (<i>RXR</i>) heterodimerizes with the <i>PPAR</i> nuclear hormone receptor and regulates its downstream events. We investigated the effects of <i>RXR</i> agonists (LG100754, bexarotene, AGN194204, and LG101506) on lenalidomide’s anti-myeloma ac...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/12/15/1993 |